Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 4 (2007), Issue 4 (April)

1. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.
   Ophthalmology, 114(4): 743-50. [Abstract] [Full-text]
2. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
   Ophthalmology, 114(4): 710-5. [Abstract] [Full-text]
3. Assessing prognosis in patients with diabetes mellitus--the Achilles' heel of cardiac stress imaging tests?
   Am J Cardiol, 99(7): 1016-9. [Abstract] [Full-text]
4. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials).
   Am J Cardiol, 99(7): 1006-12. [Abstract] [Full-text]
5. Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
   Am J Cardiol, 99(7): 956-60. [Abstract] [Full-text]
6. Value of electrocardiographic and ankle-brachial index abnormalities for prediction of coronary atherosclerosis in asymptomatic subjects with type 2 diabetes mellitus.
   Am J Cardiol, 99(7): 951-5. [Abstract] [Full-text]
7. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
   Jpn J Ophthalmol, 51(2): 100-4. [Abstract] [Full-text]
8. Unmitigated communion and health among adolescents with and without diabetes: the mediating role of eating disturbances.
   Pers Soc Psychol Bull, 33(4): 519-36. [Abstract] [Full-text]
9. Development, worsening, and improvement of diabetic microangiopathy in older people: six-year prospective study of patients under intensive diabetes control.
   J Am Geriatr Soc, 55(4): 541-7. [Abstract] [Full-text]
10. Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus.
    J Am Vet Med Assoc, 230(7): 1011-7. [Abstract] [Full-text]
11. Osmotic pressure and vasculature of gingiva in experimental diabetes mellitus.
    J Periodontol, 78(4): 757-63. [Abstract] [Full-text]
12. Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice.
    Br J Pharmacol, 150(7): 873-82. [Abstract] [Full-text]
13. Antibodies to GAD65 and peripheral nerve function in the DCCT.
    J Neuroimmunol, 185(1): 182-9. [Abstract] [Full-text]
14. Awareness of pathophysiological concepts of type 2 diabetes: a survey in 847 physicians.
    Diabetes Res Clin Pract, 76(3): 445-8. [Abstract] [Full-text]
15. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome.
    J Vasc Surg, 45(4): 751-61. [Abstract] [Full-text]
16. Biological activity of AC3174, a peptide analog of exendin-4.
    Regul Pept, 141(1): 113-9. [Abstract] [Full-text]
17. Hind limb ischemia-reperfusion in the leptin receptor deficient (db/db) mouse.
    J Surg Res, 139(1): 97-105. [Abstract] [Full-text]
18. The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes.
    Regul Pept, 141(1): 55-60. [Abstract] [Full-text]
19. Discordant expression of pro-B-type and pro-C-type natriuretic peptide in newborn infants of mothers with type 1 diabetes.
    Regul Pept, 141(1): 135-9. [Abstract] [Full-text]
20. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
    Pharmacoepidemiol Drug Saf, 16(4): 412-21. [Abstract] [Full-text]
21. Intrahippocampal administration of A beta(1-40) impairs spatial learning and memory in hyperglycemic mice.
    Neurobiol Learn Mem, 87(4): 483-94. [Abstract] [Full-text]
22. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
    Am J Physiol Endocrinol Metab, 292(4): E1213-22. [Abstract] [Full-text]
23. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
    Am J Physiol Endocrinol Metab, 292(4): E1030-40. [Abstract] [Full-text]
24. The prospective association of general and central obesity variables with incident type 2 diabetes in adults, Tehran lipid and glucose study.
    Diabetes Res Clin Pract, 76(3): 449-54. [Abstract] [Full-text]
25. Insulin secretion and insulin resistance in newly diagnosed, drug naive prediabetes and type 2 diabetes patients with/without metabolic syndrome.
    Diabetes Res Clin Pract, 76(3): 397-403. [Abstract] [Full-text]
26. Novel mutations found in mitochondrial diabetes in Chinese Han population.
    Diabetes Res Clin Pract, 76(3): 425-35. [Abstract] [Full-text]
27. The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes.
    Diabetes Res Clin Pract, 76(3): 327-34. [Abstract] [Full-text]
28. Results of the pilot study of DIADEM: a comprehensive disease management programme for type 2 diabetes.
    Diabetes Res Clin Pract, 76(3): 410-7. [Abstract] [Full-text]
29. Brazilian version of the Problem Areas in Diabetes Scale (B-PAID): validation and identification of individuals at high risk for emotional distress.
    Diabetes Res Clin Pract, 76(3): 455-9. [Abstract] [Full-text]
30. Patient education in type 2 diabetes: a randomized controlled 1-year follow-up study.
    Diabetes Res Clin Pract, 76(3): 341-50. [Abstract] [Full-text]
31. Prevention of type 2 diabetes in a primary health care setting. Interim results from the Greater Green Triangle (GGT) Diabetes Prevention Project.
    Diabetes Res Clin Pract, 76(3): 460-2. [Abstract] [Full-text]
32. Prevention of type 2 diabetes: a review.
    Diabetes Res Clin Pract, 76(3): 317-26. [Abstract] [Full-text]
33. Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain.
    Diabetes Res Clin Pract, 76(3): 436-44. [Abstract] [Full-text]
34. Vascular phenotype and subclinical inflammation in diabetic Asian Indians without overt cardiovascular disease.
    Diabetes Res Clin Pract, 76(3): 390-6. [Abstract] [Full-text]
35. Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women.
    Diabetes Res Clin Pract, 76(3): 368-77. [Abstract] [Full-text]
36. Effect of a viscous fiber-containing nutrition bar on satiety of patients with type 2 diabetes.
    Diabetes Res Clin Pract, 76(3): 335-40. [Abstract] [Full-text]
37. Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance.
    Diabetes Res Clin Pract, 76(3): 351-7. [Abstract] [Full-text]
38. Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients.
    Diabetes Res Clin Pract, 76(3): 358-67. [Abstract] [Full-text]
39. Predicting gestational diabetes: choosing the optimal early serum marker.
    Am J Obstet Gynecol, 196(4): 410.e1-6; discussion 410.e6-7. [Abstract] [Full-text]
40. Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance.
    Am J Obstet Gynecol, 196(4): 339.e1-5. [Abstract] [Full-text]
41. Combined analysis with amniotic fluid index and estimated fetal weight for prediction of severe macrosomia at birth.
    Am J Obstet Gynecol, 196(4): 333.e1-4. [Abstract] [Full-text]
42. Putting pancreatic cell plasticity to the test.
    J Clin Invest, 117(4): 859-62. [Abstract] [Full-text]
43. The Idd6.2 diabetes susceptibility region controls defective expression of the Lrmp gene in nonobese diabetic (NOD) mice.
    Immunogenetics, 59(5): 407-16. [Abstract] [Full-text]
44. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
    Prog Retin Eye Res, 26(3): 205-38. [Abstract] [Full-text]
45. Diabetes mellitus and pyogenic liver abscess: risk and prognosis.
    Clin Infect Dis, 44(9): 1194-201. [Abstract] [Full-text]
46. Oral antidiabetic agents in type 2 diabetes.
    Curr Med Res Opin, 23(4): 945-52. [Abstract] [Full-text]
47. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.
    Curr Med Res Opin, 23(4): 933-44. [Abstract] [Full-text]
48. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
    Curr Med Res Opin, 23(4): 919-31. [Abstract] [Full-text]
49. Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control.
    Curr Med Res Opin, 23(4): 905-17. [Abstract] [Full-text]
50. An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK.
    Curr Med Res Opin, 23(4): 895-901. [Abstract] [Full-text]
51. In-hospital treatment of hyperglycemia: effects of intensified subcutaneous insulin treatment.
    Curr Med Res Opin, 23(4): 757-65. [Abstract] [Full-text]
52. Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice.
    Curr Med Res Opin, 23(4): 713-9. [Abstract] [Full-text]
53. beta-cell failure in diabetes and preservation by clinical treatment.
    Endocr Rev, 28(2): 187-218. [Abstract] [Full-text]
54. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup.
    Clin Chem, 53(4): 711-6. [Abstract] [Full-text]
55. A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes.
    Am J Physiol Regul Integr Comp Physiol, 292(4): R1381-90. [Abstract] [Full-text]
56. Truncated pStat5B is associated with the Idd4 locus in NOD mice.
    Biochem Biophys Res Commun, 356(3): 655-61. [Abstract] [Full-text]
57. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study.
    Eye, 21(4): 465-71. [Abstract] [Full-text]
58. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    Am J Physiol Renal Physiol, 292(4): F1141-50. [Abstract] [Full-text]
59. Evaluation of the effect of JPEG and JPEG2000 image compression on the detection of diabetic retinopathy.
    Eye, 21(4): 487-93. [Abstract] [Full-text]
60. The treatment of diabetic foot ulcers: reviewing the literature and a surgical algorithm.
    Adv Skin Wound Care, 20(4): 227-37; quiz 237-9. [Abstract] [Full-text]
61. Effect of insufficient insulin treatment in streptozotocin-induced diabetes mellitus.
    Pancreas, 34(3): 354-8. [Abstract] [Full-text]
62. Quality of diabetes care among adults with serious mental illness.
    Psychiatr Serv, 58(4): 536-43. [Abstract] [Full-text]
63. Moving towards efficient therapies in type 1 diabetes: to combine or not to combine?
    Autoimmun Rev, 6(5): 315-22. [Abstract] [Full-text]
64. Application of DNA microarrays in the study of human obesity and type 2 diabetes.
    OMICS, 11(1): 25-40. [Abstract] [Full-text]
65. Synthesis and in vivo antihyperglycemic activity of nature-mimicking furanyl-2-pyranones in STZ-S model.
    Bioorg Med Chem Lett, 17(9): 2425-9. [Abstract] [Full-text]
66. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus.
    Int J Cardiol, 117(3): 411-2. [Abstract] [Full-text]
67. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
    Placenta, 28(4): 315-23. [Abstract] [Full-text]
68. Renin-angiotensin system and cardiovascular risk.
    Lancet, 369(9568): 1208-19. [Abstract] [Full-text]
69. Culturally competent interventions for Hispanic adults with type 2 diabetes: a systematic review.
    J Transcult Nurs, 18(2): 157-66. [Abstract] [Full-text]
70. Macular edema in unregulated type 2 diabetic patients following glycemic control.
    Arch Med Res, 38(4): 398-402. [Abstract] [Full-text]
71. Inhibitory action of protein kinase Cbeta inhibitor on tetrodotoxin-resistant Na+ current in small dorsal root ganglion neurons in diabetic rats.
    Neurosci Lett, 417(1): 90-4. [Abstract] [Full-text]
72. Medial plantar nerve conduction studies in healthy controls and diabetics.
    Clin Neurophysiol, 118(5): 1155-61. [Abstract] [Full-text]
73. Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy.
    J Mol Cell Cardiol, 42(4): 884-95. [Abstract] [Full-text]
74. Cataract associated with type-1 diabetes mellitus in the pediatric population.
    J AAPOS, 11(2): 162-5. [Abstract] [Full-text]
75. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients.
    Nitric Oxide, 16(3): 348-55. [Abstract] [Full-text]
76. A statistical model for inter-temporal causal dynamics of glucose production and disposal with insulin level in diabetic patients.
    Stat Med, 26(8): 1730-44. [Abstract] [Full-text]
77. Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats.
    J Ethnopharmacol, 111(2): 430-4. [Abstract] [Full-text]
78. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
    J Ethnopharmacol, 111(2): 240-7. [Abstract] [Full-text]
79. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
    Int J Cardiol, 118(1): 88-96. [Abstract] [Full-text]
80. Antihypertensive medications and risk of diabetes mellitus.
    Curr Opin Nephrol Hypertens, 16(3): 256-60. [Abstract] [Full-text]
81. New insights into structural patterns encountered in glomerulosclerosis.
    Curr Opin Nephrol Hypertens, 16(3): 184-91. [Abstract] [Full-text]
82. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    Arch Intern Med, 167(7): 642-8. [Abstract] [Full-text]
83. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
    Arch Ophthalmol, 125(4): 469-80. [Abstract] [Full-text]
84. Relation of diabetes to mild cognitive impairment.
    Arch Neurol, 64(4): 570-5. [Abstract] [Full-text]
85. No loss of genomic imprinting of IGF-II and H19 in placentas of diabetic pregnancies with fetal macrosomia.
    Growth Horm IGF Res, 17(2): 130-6. [Abstract] [Full-text]
86. Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine.
    Am J Physiol Heart Circ Physiol, 292(4): H1728-36. [Abstract] [Full-text]
87. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
    JAMA, 297(14): 1568-76. [Abstract] [Full-text]
88. Protection against oxidative stress in diabetic rats by wheat bran feruloyl oligosaccharides.
    J Agric Food Chem, 55(8): 3191-5. [Abstract] [Full-text]
89. A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
    Am J Epidemiol, 165(9): 1047-54. [Abstract] [Full-text]
90. Bayesian analysis of structural equation models with multinomial variables and an application to type 2 diabetic nephropathy.
    Stat Med, 26(11): 2348-69. [Abstract] [Full-text]
91. Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
    N Engl J Med, 356(15): 1517-26. [Abstract] [Full-text]
92. Cellular and molecular pathogenesis of type 1A diabetes.
    Cell Mol Life Sci, 64(7): 865-72. [Abstract] [Full-text]
93. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Immunology, 121(1): 15-28. [Abstract] [Full-text]
94. Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart.
    Am J Physiol Cell Physiol, 292(4): C1370-8. [Abstract] [Full-text]
95. Diabetes: the latest trends in glycemic control.
    Clin Podiatr Med Surg, 24(2): 159-89. [Abstract] [Full-text]
96. Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice.
    J Pharm Pharmacol, 59(4): 575-82. [Abstract] [Full-text]
97. Progression of retinopathy during pregnancy in type 1 diabetes mellitus.
    Clin Experiment Ophthalmol, 35(3): 231-6. [Abstract] [Full-text]
98. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore.
    Prev Med, 44(4): 335-40. [Abstract] [Full-text]
99. Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy.
    Acta Neurol Scand, 115(4): 284-8. [Abstract] [Full-text]
100. Clinical and medication profiles stratified by household income in patients referred for diabetes care.
     Cardiovasc Diabetol, 6: 11. [Abstract] [Full-text]
101. On the road to the national objectives: a case study of Diabetes Prevention and Control Programs.
     J Public Health Manag Pract, 13(3): 287-95. [Abstract] [Full-text]
102. Drug delivery methods for posterior segment disease.
     Curr Opin Ophthalmol, 18(3): 235-9. [Abstract] [Full-text]
103. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy.
     Neurosci Lett, 417(2): 149-54. [Abstract] [Full-text]
104. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
     Pharmacol Res, 55(5): 400-7. [Abstract] [Full-text]
105. Diabetes care for patients with peripheral arterial disease.
     Eur J Vasc Endovasc Surg, 33(5): 583-91. [Abstract] [Full-text]
106. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
     Vascul Pharmacol, 46(6): 456-62. [Abstract] [Full-text]
107. Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats.
     Pharmacol Res, 55(5): 433-40. [Abstract] [Full-text]
108. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid.
     Pharmacol Res, 55(5): 385-91. [Abstract] [Full-text]
109. Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study.
     Eur J Vasc Endovasc Surg, 33(5): 599-604. [Abstract] [Full-text]
110. Preventive effects of fenofibrate on insulin resistance, hyperglycaemia, visceral fat accumulation in NIH mice induced by small-dose streptozotocin and lard.
     Pharmacol Res, 55(5): 392-9. [Abstract] [Full-text]
111. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
     Clin Exp Immunol, 148(1): 72-8. [Abstract] [Full-text]
112. Propagation of the cardiac impulse in the diabetic rat heart: reduced conduction reserve.
     J Physiol, 580: 543-60. [Abstract] [Full-text]
113. Reduced aortic wall stress in diabetes mellitus.
     Eur J Vasc Endovasc Surg, 33(5): 592-8. [Abstract] [Full-text]
114. Enhanced NTPDase and 5'-nucleotidase activities in diabetes mellitus and iron-overload model.
     Mol Cell Biochem, 298(1): 101-7. [Abstract] [Full-text]
115. Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: rationale and specific agents.
     Clin Pharmacol Ther, 81(5): 636-49. [Abstract] [Full-text]
116. Inhalation of glutamic acid decarboxylase 65-derived peptides can protect against recurrent autoimmune but not alloimmune responses in the non-obese diabetic mouse.
     Clin Exp Immunol, 148(2): 368-72. [Abstract] [Full-text]
117. Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats.
     Life Sci, 80(20): 1832-8. [Abstract] [Full-text]
118. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
     Clin Pharmacol Ther, 81(5): 761-7. [Abstract] [Full-text]
119. Prediction and prevention of type 1 diabetes: progress, problems, and prospects.
     Clin Pharmacol Ther, 81(5): 768-71. [Abstract] [Full-text]
120. Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
     J Neurol Sci, 256(1): 100-2. [Abstract] [Full-text]
121. Bevacizumab for neovascular ocular diseases.
     Ann Pharmacother, 41(4): 614-25. [Abstract] [Full-text]
122. Does diabetes mellitus target motor neurons?
     Neurobiol Dis, 26(2): 301-11. [Abstract] [Full-text]
123. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
     J Pharmacol Exp Ther, 321(2): 431-8. [Abstract] [Full-text]
124. Melatonin and type 2 diabetes - a possible link?
     J Pineal Res, 42(4): 350-8. [Abstract] [Full-text]
125. Diabetic rats supplemented with L-glutamine: a study of immunoreactive myosin-V myenteric neurons and the proximal colonic mucosa.
     Dig Dis Sci, 52(5): 1233-41. [Abstract] [Full-text]
126. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
127. Meglitinide analogues for type 2 diabetes mellitus.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
128. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
129. Associations of patient health-related problem solving with disease control, emergency department visits, and hospitalizations in HIV and diabetes clinic samples.
     J Gen Intern Med, 22(5): 649-54. [Abstract] [Full-text]
130. Group visits: promoting adherence to diabetes guidelines.
     J Gen Intern Med, 22(5): 620-4. [Abstract] [Full-text]
131. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.
     J Clin Oncol, 25(12): 1476-81. [Abstract] [Full-text]
132. The emergence of mucormycosis as an important opportunistic fungal infection: five cases presenting to a tertiary referral center for mycology.
     Int J Dermatol, 46(4): 380-4. [Abstract] [Full-text]
133. Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians.
     BMC Med Genet, 8: 20. [Abstract] [Full-text]
134. Hyperglycemia and diabetic renal change in a model of polyvinyl alcohol bioartificial pancreas transplantation.
     Pancreas, 34(4): 458-65. [Abstract] [Full-text]
135. A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage.
     Br J Ophthalmol, 91(5): 677-89. [Abstract] [Full-text]
136. Rat strain-dependent susceptibility to ischemia-induced retinopathy associated with retinal vascular endothelial growth factor regulation.
     J Mol Endocrinol, 38(4): 423-32. [Abstract] [Full-text]
137. Lower urinary tract symptoms and uroflowmetry in women with type 2 diabetes mellitus with and without bladder dysfunction.
     Urology, 69(4): 685-90. [Abstract] [Full-text]
138. First case of simultaneous heart plus kidney transplantation in Chile: case report.
     Transplant Proc, 39(3): 625-6. [Abstract] [Full-text]
139. Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus.
     Metabolism, 56(5): 693-8. [Abstract] [Full-text]
140. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
     Metabolism, 56(5): 676-85. [Abstract] [Full-text]
141. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
     Metabolism, 56(5): 670-5. [Abstract] [Full-text]
142. A common interleukin 18 haplotype is associated with higher body mass index in subjects with diabetes and coronary heart disease.
     Metabolism, 56(5): 662-9. [Abstract] [Full-text]
143. Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus.
     Metabolism, 56(5): 656-61. [Abstract] [Full-text]
144. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
     Metabolism, 56(5): 649-55. [Abstract] [Full-text]
145. Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus.
     Metabolism, 56(5): 623-8. [Abstract] [Full-text]
146. Impact of low-density lipoprotein particle size on carotid intima-media thickness in patients with type 2 diabetes mellitus.
     Metabolism, 56(5): 608-13. [Abstract] [Full-text]
147. Long-term consumption of caffeine improves glucose homeostasis by enhancing insulinotropic action through islet insulin/insulin-like growth factor 1 signaling in diabetic rats.
     Metabolism, 56(5): 599-607. [Abstract] [Full-text]
148. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort.
     Metabolism, 56(5): 587-92. [Abstract] [Full-text]
149. Canine DLA diversity: 3. Disease studies.
     Tissue Antigens, 69: 292-6. [Abstract] [Full-text]
150. 14th International HLA and Immunogenetics Workshop: report on the HLA component of type 1 diabetes.
     Tissue Antigens, 69: 214-25. [Abstract] [Full-text]
151. Modelling KIR-HLA genotype disparities in type 1 diabetes.
     Tissue Antigens, 69: 101-5. [Abstract] [Full-text]
152. The Collaborative Study of Obesity and Diabetes in Adults (CODA) project: meta-analysis design and description of participating studies.
     Obes Rev, 8(3): 263-76. [Abstract] [Full-text]
153. Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects.
     Obes Rev, 8(3): 231-51. [Abstract] [Full-text]
154. Experimental IUGR and later diabetes.
     J Intern Med, 261(5): 437-52. [Abstract] [Full-text]
155. Epidemiology, genes and the environment: lessons learned from the Helsinki Birth Cohort Study.
     J Intern Med, 261(5): 418-25. [Abstract] [Full-text]
156. Evaluation of the vascular targeting agent combretastatin a-4 prodrug on retinal neovascularization in the galactose-fed dog.
     J Ocul Pharmacol Ther, 23(2): 132-42. [Abstract] [Full-text]
157. Topically applied naltrexone restores corneal reepithelialization in diabetic rats.
     J Ocul Pharmacol Ther, 23(2): 89-102. [Abstract] [Full-text]
158. Association between frequency of telephonic contact and clinical testing for a large, geographically diverse diabetes disease management population.
     Dis Manag, 10(2): 101-9. [Abstract] [Full-text]
159. Development of a disease-specific model to evaluate endothelial dysfunction in patients with diabetes mellitus.
     Biochem Biophys Res Commun, 357(1): 308-13. [Abstract] [Full-text]
160. Glucose regulation of CDK7, a putative thiol related gene, in experimental diabetic nephropathy.
     Biochem Biophys Res Commun, 357(1): 237-44. [Abstract] [Full-text]
161. Diabetes self-management: perspectives of Latino patients and their health care providers.
     Patient Educ Couns, 66(2): 202-10. [Abstract] [Full-text]
162. Diabetes attenuates psychological stress-elicited 5-HT secretion in the prefrontal cortex but not in the amygdala of mice.
     Brain Res, 1147: 233-9. [Abstract] [Full-text]
163. Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
     Endocrinology, 148(5): 2198-208. [Abstract] [Full-text]
164. Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways.
     Endocrinology, 148(5): 2016-26. [Abstract] [Full-text]
165. Prenatal and postnatal pathways to obesity: different underlying mechanisms, different metabolic outcomes.
     Endocrinology, 148(5): 2345-54. [Abstract] [Full-text]
166. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization.
     Endocrinology, 148(5): 2006-15. [Abstract] [Full-text]
167. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms.
     J Infect, 54(5): 439-45. [Abstract] [Full-text]
168. Family history of diabetes, awareness of risk factors, and health behaviors among African Americans.
     Am J Public Health, 97(5): 907-12. [Abstract] [Full-text]
169. Monitoring health related quality of life in adolescents with diabetes: a review of measures.
     Arch Dis Child, 92(5): 434-9. [Abstract] [Full-text]
170. Diabetic myonecrosis in an orthotopic heart transplant recipient.
     J Heart Lung Transplant, 26(5): 549-52. [Abstract] [Full-text]
171. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.
     J Am Coll Cardiol, 49(16): 1696-704. [Abstract] [Full-text]
172. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.
     Pediatr Diabetes, 8(2): 74-87. [Abstract] [Full-text]
173. Marked increase in type 1 diabetes mellitus incidence in children aged 0-14 yr in Victoria, Australia, from 1999 to 2002.
     Pediatr Diabetes, 8(2): 67-73. [Abstract] [Full-text]
174. Incidence of type 1 diabetes mellitus in the 0- to 17-yr-old Israel population, 1997-2003.
     Pediatr Diabetes, 8(2): 60-6. [Abstract] [Full-text]
175. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
     Pediatr Diabetes, 8(2): 53-9. [Abstract] [Full-text]
176. Patient Engagement and Coaching for Health: The PEACH study--a cluster randomised controlled trial using the telephone to coach people with type 2 diabetes to engage with their GPs to improve diabetes care: a study protocol.
     BMC Fam Pract, 8: 20. [Abstract] [Full-text]
177. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts.
     J Biol Chem, 282(17): 12363-7. [Abstract] [Full-text]
178. Retinal arteriolar hemodynamic response to an acute hyperglycemic provocation in early and sight-threatening diabetic retinopathy.
     Microvasc Res, 73(3): 191-7. [Abstract] [Full-text]
179. Estimating stage occupation probabilities in non-Markov models.
     Lifetime Data Anal, 13(2): 211-40. [Abstract] [Full-text]
180. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy.
     J Biol Chem, 282(17): 12467-74. [Abstract] [Full-text]
181. UK GPs' and practice nurses' views of continuity of care for patients with type 2 diabetes.
     Fam Pract, 24(2): 128-37. [Abstract] [Full-text]
182. Exercise training improves arterial baro- and chemoreflex in control and diabetic rats.
     Auton Neurosci, 133(2): 115-20. [Abstract] [Full-text]
183. Sight-threatening retinopathy is associated with lower mortality in type 2 diabetic subjects: a 10-year observation study.
     Diabetes Res Clin Pract, 77(1): 141-7. [Abstract] [Full-text]
184. Differences in coronary heart disease prevalence and risk factors in African and White patients with type 2 diabetes.
     Diabetes Res Clin Pract, 77(1): 107-12. [Abstract] [Full-text]
185. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients.
     Diabetes Res Clin Pract, 77(1): 77-83. [Abstract] [Full-text]
186. HbA1c is outcome predictor in diabetic patients with sepsis.
     Diabetes Res Clin Pract, 77(1): 120-5. [Abstract] [Full-text]
187. Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes.
     Diabetes Res Clin Pract, 77(1): 70-6. [Abstract] [Full-text]
188. VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile.
     Diabetes Res Clin Pract, 77(1): 134-40. [Abstract] [Full-text]
189. Treatment of diabetic ketoacidosis in adults in Denmark: a national survey.
     Diabetes Res Clin Pract, 77(1): 113-9. [Abstract] [Full-text]
190. Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes.
     Diabetes Res Clin Pract, 77(1): 58-61. [Abstract] [Full-text]
191. Undertreatment of cardiovascular risk factors among persons with diabetes in the United States.
     Diabetes Res Clin Pract, 77(1): 126-33. [Abstract] [Full-text]
192. A review of human and analogue insulin trials.
     Diabetes Res Clin Pract, 77(1): 1-15. [Abstract] [Full-text]
193. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory.
     Diabetes Res Clin Pract, 77(1): 47-57. [Abstract] [Full-text]
194. Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: comparison of two treatment algorithms using insulin glargine.
     Diabetes Res Clin Pract, 77(1): 84-91. [Abstract] [Full-text]
195. Total and excess bed occupancy by age, specialty and insulin use for nearly one million diabetes patients discharged from all English Acute Hospitals.
     Diabetes Res Clin Pract, 77(1): 92-8. [Abstract] [Full-text]
196. Cystic fibrosis related diabetes in an extremely young patient.
     J Cyst Fibros, 6(3): 247-9. [Abstract] [Full-text]
197. Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects.
     Diabetes Res Clin Pract, 77(1): 148-50. [Abstract] [Full-text]
198. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.
     Diabetes Res Clin Pract, 77(1): 151-4. [Abstract] [Full-text]
199. The relationship between parent-reported social support and adherence to medical treatment in families of adolescents with type 1 diabetes.
     J Pediatr Psychol, 32(4): 427-36. [Abstract] [Full-text]
200. Child routines and youths' adherence to treatment for type 1 diabetes.
     J Pediatr Psychol, 32(4): 437-47. [Abstract] [Full-text]
201. Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports.
     J Cyst Fibros, 6(3): 237-40. [Abstract] [Full-text]
202. The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes.
     Disabil Rehabil, 29(9): 689-700. [Abstract] [Full-text]
203. Assessment of automated screening for treatment-requiring diabetic retinopathy.
     Curr Eye Res, 32(4): 331-6. [Abstract] [Full-text]
204. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients.
     Transplantation, 83(8): 1027-34. [Abstract] [Full-text]
205. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study.
     Arch Intern Med, 167(8): 802-7. [Abstract] [Full-text]
206. Sulfonylurea-responsive diabetes in childhood.
     J Pediatr, 150(5): 553-5. [Abstract] [Full-text]
207. Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis.
     J Pediatr, 150(5): 467-73. [Abstract] [Full-text]
208. Impact of celiac autoimmunity on children with type 1 diabetes.
     J Pediatr, 150(5): 461-6. [Abstract] [Full-text]
209. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
     Circulation, 115(16): 2178-87. [Abstract] [Full-text]
210. Developmental origins of beta-cell failure in type 2 diabetes: the role of epigenetic mechanisms.
     Pediatr Res, 61(5): 64R-67R. [Abstract] [Full-text]
211. Strong diabetes.
     Br J Sports Med, 41(5): 335-6; discussion 336. [Abstract] [Full-text]
212. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
     Atherosclerosis, 192(1): 204-10. [Abstract] [Full-text]
213. LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.
     Atherosclerosis, 192(1): 138-47. [Abstract] [Full-text]
214. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?
     Atherosclerosis, 192(1): 161-8. [Abstract] [Full-text]
215. Diabetes: caught in the Akt?
     Kidney Int, 71(9): 839-41. [Abstract] [Full-text]
216. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
     Am J Pathol, 170(5): 1473-84. [Abstract] [Full-text]
217. Methods of measuring insulin sensitivity.
     Biol Res Nurs, 8(4): 305-18. [Abstract] [Full-text]
218. Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells.
     Biochem Biophys Res Commun, 357(2): 414-20. [Abstract] [Full-text]
219. Changes in depressive symptoms and glycemic control in diabetes mellitus.
     Psychosom Med, 69(3): 235-41. [Abstract] [Full-text]
220. The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis.
     Lipids Health Dis, 6: 9. [Abstract] [Full-text]
221. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.
     PLoS Med, 4(4): e118. [Abstract] [Full-text]
222. Estimated risk for undiagnosed diabetes in the emergency department: a multicenter survey.
     Acad Emerg Med, 14(5): 492-5. [Abstract] [Full-text]
223. Phenotypic transitions and fibrosis in diabetic nephropathy.
     Kidney Int, 71(9): 846-54. [Abstract] [Full-text]
224. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice.
     Kidney Int, 71(9): 912-23. [Abstract] [Full-text]
225. Transcriptional profiling of type 1 diabetes genes on chromosome 21 in a rat beta-cell line and human pancreatic islets.
     Genes Immun, 8(3): 232-8. [Abstract] [Full-text]
226. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?
     Nucl Med Commun, 28(6): 465-72. [Abstract] [Full-text]
227. Loss of insulin-mediated vasoprotection: early effect of diabetes on pericyte-containing microvessels of the retina.
     Invest Ophthalmol Vis Sci, 48(5): 2350-5. [Abstract] [Full-text]
228. Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis.
     Invest Ophthalmol Vis Sci, 48(5): 2260-7. [Abstract] [Full-text]
229. The importance of serum lipids in exudative diabetic macular edema in type 2 diabetic patients.
     Ann N Y Acad Sci, 1100: 213-7. [Abstract] [Full-text]
230. Antioxidant enzymes and diabetic retinopathy.
     Ann N Y Acad Sci, 1100: 199-206. [Abstract] [Full-text]
231. Identification of a candidate genetic variant for the high prevalence of type II diabetes in Polynesians.
     Eur J Hum Genet, 15(5): 584-9. [Abstract] [Full-text]
232. Concern, pressure and lack of knowledge affect choice of not wanting to know high-risk status.
     Eur J Hum Genet, 15(5): 556-62. [Abstract] [Full-text]
233. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort.
     J Acquir Immune Defic Syndr, 45(1): 66-71. [Abstract] [Full-text]
234. A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.
     Pediatr Nephrol, 22(5): 670-3. [Abstract] [Full-text]
235. Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan.
     J Gastroenterol, 42(4): 291-7. [Abstract] [Full-text]
236. Endothelial mitochondria: contributing to vascular function and disease.
     Circ Res, 100(8): 1128-41. [Abstract] [Full-text]
237. Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes.
     Hum Immunol, 68(5): 384-91. [Abstract] [Full-text]
238. Bacteremia causes mycotic aneurysm of the aortic arch in 110 days.
     Ann Thorac Surg, 83(5): 1874-6. [Abstract] [Full-text]
239. Liver disease as risk factor for cystic fibrosis-related diabetes development.
     Acta Paediatr, 96(5): 736-9. [Abstract] [Full-text]
240. CD36 deficiency rescues lipotoxic cardiomyopathy.
     Circ Res, 100(8): 1208-17. [Abstract] [Full-text]
241. Pycnanthuquinone C, an unusual 6,6,5-tricyclic Geranyltoluquinone from the Western Australian brown alga Cystophora harveyi.
     J Nat Prod, 70(4): 671-4. [Abstract] [Full-text]
242. Prejudice towards chronic diseases: comparison among epilepsy, AIDS and diabetes.
     Seizure, 16(4): 320-3. [Abstract] [Full-text]
243. Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes.
     Immunology, 121(2): 189-96. [Abstract] [Full-text]
244. Racialized genetics and the study of complex diseases: the thrifty genotype revisited.
     Perspect Biol Med, 50(2): 203-27. [Abstract] [Full-text]
245. Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes.
     Diabetes Care, 30(5): 1069-74. [Abstract] [Full-text]
246. Metabolic follow-up after long-term pancreas graft survival.
     Eur J Endocrinol, 156(5): 603-10. [Abstract] [Full-text]
247. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.
     Eur J Endocrinol, 156(5): 595-602. [Abstract] [Full-text]
248. Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure.
     Am J Health Syst Pharm, 64(9): 931-6. [Abstract] [Full-text]
249. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
     Ophthalmology, 114(5): 890-4. [Abstract] [Full-text]
250. Impaired integration of endothelial progenitor cells in capillaries of diabetic wounds is reversible with vascular endothelial growth factor infusion.
     Transl Res, 149(5): 282-91. [Abstract] [Full-text]
251. A prognostic model for 1-year mortality in older adults after hospital discharge.
     Am J Med, 120(5): 455-60. [Abstract] [Full-text]
252. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.
     J Am Coll Cardiol, 49(17): 1772-80. [Abstract] [Full-text]
253. Fatty acid receptors as new therapeutic targets for diabetes.
     Expert Opin Ther Targets, 11(5): 661-71. [Abstract] [Full-text]
254. Hrs is a positive regulator of VEGF and insulin signaling.
     Exp Cell Res, 313(9): 1927-42. [Abstract] [Full-text]
255. Quality of care: assessment.
     Lipids Health Dis, 6: 12. [Abstract] [Full-text]
256. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.
     Clin Chem, 53(5): 897-901. [Abstract] [Full-text]
257. Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes.
     J Biol Chem, 282(18): 13854-63. [Abstract] [Full-text]
258. Motivational interviewing improves weight loss in women with type 2 diabetes.
     Diabetes Care, 30(5): 1081-7. [Abstract] [Full-text]
259. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy.
     Diabetes Care, 30(5): 1162-7. [Abstract] [Full-text]
260. A1C and survival in maintenance hemodialysis patients.
     Diabetes Care, 30(5): 1049-55. [Abstract] [Full-text]
261. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.
     Diabetes Care, 30(5): 1120-4. [Abstract] [Full-text]
262. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements.
     Diabetes Care, 30(5): 1125-30. [Abstract] [Full-text]
263. Knowledge on inpatient diabetes among fourth-year medical students.
     Diabetes Care, 30(5): 1088-91. [Abstract] [Full-text]
264. Microvascular complications in cystic fibrosis-related diabetes.
     Diabetes Care, 30(5): 1056-61. [Abstract] [Full-text]
265. Benefits of information technology-enabled diabetes management.
     Diabetes Care, 30(5): 1137-42. [Abstract] [Full-text]
266. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes.
     Diabetes Care, 30(5): 1233-40. [Abstract] [Full-text]
267. Identification of distinct self-management styles of adolescents with type 1 diabetes.
     Diabetes Care, 30(5): 1107-12. [Abstract] [Full-text]
268. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus.
     Diabetes Care, 30(5): 1102-6. [Abstract] [Full-text]
269. Adipokines and risk of type 2 diabetes in older men.
     Diabetes Care, 30(5): 1200-5. [Abstract] [Full-text]
270. Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric.
     Diabetes Care, 30(5): 1131-6. [Abstract] [Full-text]
271. Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial.
     Diabetes Care, 30(5): 1092-6. [Abstract] [Full-text]
272. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
     Diabetes Care, 30(5): 1248-54. [Abstract] [Full-text]
273. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients.
     Diabetes Care, 30(5): 1255-60. [Abstract] [Full-text]
274. Androgenicity of progestins in hormonal contraceptives and the risk of gestational diabetes mellitus.
     Diabetes Care, 30(5): 1062-8. [Abstract] [Full-text]
275. Recurrence of gestational diabetes mellitus: a systematic review.
     Diabetes Care, 30(5): 1314-9. [Abstract] [Full-text]
276. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity.
     Diabetes Care, 30(5): 1193-9. [Abstract] [Full-text]
277. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
     Diabetes Care, 30(5): 1241-7. [Abstract] [Full-text]
278. Using continuous glucose monitoring to measure the frequency of low glucose values when using biphasic insulin aspart 30 compared with biphasic human insulin 30: a double-blind crossover study in individuals with type 2 diabetes.
     Diabetes Care, 30(5): 1044-8. [Abstract] [Full-text]
279. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
     Diabetes Care, 30(5): 1212-8. [Abstract] [Full-text]
280. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
     Ophthalmology, 114(5): 881-9. [Abstract] [Full-text]
281. Physiological regulation of the pancreatic {beta}-cell: functional insights for understanding and therapy of diabetes.
     Exp Physiol, 92(3): 481-96. [Abstract] [Full-text]
282. Endothelial function varies according to insulin resistance disease type.
     Diabetes Care, 30(5): 1226-32. [Abstract] [Full-text]
283. Noninvasive assessment of plaque characteristics with multislice computed tomography coronary angiography in symptomatic diabetic patients.
     Diabetes Care, 30(5): 1113-9. [Abstract] [Full-text]
284. Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients.
     Diabetes Care, 30(5): 1156-61. [Abstract] [Full-text]
285. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
     Diabetes Care, 30(5): 1206-11. [Abstract] [Full-text]
286. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
     Diabetes Care, 30(5): 1150-5. [Abstract] [Full-text]
287. Rising incidence of type 2 diabetes in children in the U.K.
     Diabetes Care, 30(5): 1097-101. [Abstract] [Full-text]
288. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
     Diabetes Care, 30(5): 1219-25. [Abstract] [Full-text]
289. Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle.
     Am J Physiol Endocrinol Metab, 292(5): E1301-7. [Abstract] [Full-text]
290. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
     Am J Physiol Endocrinol Metab, 292(5): E1288-94. [Abstract] [Full-text]
291. A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile.
     J Chromatogr B Analyt Technol Biomed Life Sci, 850(1): 236-40. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.